Work

Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer

Year: 2017

Type: article

Source: Science Signaling

DOI: 10.1126/scisignal.aal2328

Authors: Xin Chen, Joost J. Oppenheim

Institutions: University of Macau, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Center for Cancer Research, Science and Technology Development Fund, Universidade de Macau, National Institutes of Health, National Cancer Institute

Awards: G4420560370, G6940599432, G7045653347

OpenAlex ID: W2574330890

FWCI: 3.256

Cites: 10

Cited by: 79

Related to: 10